The ability of the Geneva homologous recombination deficiency (HRD) test to predict progression-free survival (PFS) in patients with high-grade ovarian cancer treated with poly (ADP-ribose) polymerase ...
PITTSBURGH, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (POAI), a leader in AI-driven drug discovery and biologics, today provided an update highlighting new successes with its drug ...
Please provide your email address to receive an email when new articles are posted on . The Merlin test, a clinical-pathologic and gene expression profile, was able to successfully classify 37% of ...
November 19, 2007 (New Orleans) — The Brückner test (BT) was suggested as a screening option for children who could not receive the usual methods of screening in a study presented here at the American ...
The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...
An investigational blood test for early detection of colorectal cancer (CRC) in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC study, the largest study ...
A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results